Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Inhibikase Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · Wilmington, DE, United States

  1. PrincipalsChristopher CabellPresident & Head of R&DDavid McIntyreChief Financial OfficerMark T IwickiChief Executive Officerand 2 more
  2. CompanyInhibikase Therapeutics, Inc.Wilmington, DE, United States
  3. Phone line+1 (302) 295-3800General business
Request a quote

Inhibikase Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker IKT) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 5

Chief executive

Christopher CabellPresident & Head of R&D
Mark T IwickiChief Executive Officer

Chair & board

Amit MunshiDirector (Board)
Vincent AurentzDirector (Board)

Finance

David McIntyreChief Financial Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Christopher Cabell — President & Head of R&D

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. David McIntyre — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Mark T Iwicki — Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers